In what has been described as the biggest reform of divorce laws for 50 years, couples in England and Wales will not have to either separate for at least two years – increasing to five if one party does not consent – or allocate blame to legally end their marriage.
Read More »
Two-time Oscar winning Iranian film director Asghar Farhadi has been found guilty of plagiarizing a film student’s work for his new film A Hero by an Iranian court in Tehran.
Read More »
Jordan Prince Hamzah bin al-Hussein has announced he is relinquishing his royal title over a family feud that has included allegations of corruption, a house arrest, and power struggles.
Read More »
A pilot who lied about his flying experience to get a job with British Airways CityFlyer has been jailed, the Civil Aviation Authority (CAA) said.
Read More »
Actor Bruce Willis’ family has announced the diagnosis of a rare form of a neurodegenerative condition that has now brought an end to his acting career.
Read More »
Probably the first good thing to have happened to comedian Chris Rock after Will Smith slapped him at the Oscars last Sunday – a massive uptake tickets sales for his ongoing Ego Death world tour.
Read More »
Renowned Ghanaian-British Architect David Adjaye was among seven global leaders honoured for the way they’ve pushed their industries forward at the TIME 100 Impact Awards and Gala held Monday 28 March at Dubai’s Museum of the Future, UAE.
Read More »
A 31-year-old Ugandan traditional healer living in South Africa illegally has been handed a 30-year prison term for defrauding a miner of his R955 300 pension money under the pretense that it would multiply into millions.
Read More »
Still fighting extradition to the United States, where he is wanted for an alleged conspiracy to obtain and disclose national defence information, Wikileaks founder, Julian Assange has married his fiancée at Belmarsh high-security prison in south-east London.
Read More »
A non-hormonal birth control pill found to be 99 per cent effective at preventing pregnancy in test on mice with no observed side effects. Human trials are being planned, but some researchers warn that safety concerns could yet prevent the drug from making it to the market.
Read More »